case_id,count,combos,patient_info,document_name,Q4_baseline,Q4_rag,Q4_gt
Case3474,14,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_gpt_5_mini_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_mini_update', 'top1_30retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_mini_update']","The patient is a 5-year-old who was evaluated by a medical geneticist for congenital choanal atresia and whole genome sequencing (WGS) is being ordered to assess for an underlying genetic etiology or syndromic association given the structural airway anomaly and a reported older sibling with developmental delay, prior karyotype testing was nondiagnostic, pre-test genetic counseling has been completed on multiple occasions with plans for post-test follow-up, and testing is being pursued with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case15834,13,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_gpt_5_mini_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_mini_gpt_5_update', 'top1_30retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']","The infant is being evaluated for concern for autism spectrum disorder based on early signs and was referred by the primary care physician for genetic assessment; whole exome sequencing (WES) has been ordered to assess for an underlying genetic etiology, and prior Fragile X testing was nondiagnostic. There is a family history of a maternal aunt with a congenital anomaly. Pre-test counseling was completed with a genetic specialist and testing will be pursued with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case7297,13,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_mini_update', 'top1_30retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_mini_update']","This 3-year-old child was referred by a family medicine physician for evaluation of multiple congenital anomalies affecting different organ systems; prior karyotype testing was nondiagnostic and whole exome sequencing (WES) is being pursued to identify an underlying genetic etiology, the family reports a maternal aunt with ovarian cancer which raises concern for a possible familial predisposition, pre-test counseling was completed with a genetic specialist with plans for post-test follow-up, and the family has coverage through UHC and consents to WES to guide diagnosis, management, and cascade testing if indicated.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case7014,12,"['top1_10retrieve_gpt_5_gpt_5_mini_update', 'top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_mini_update']","An infant aged seven weeks was referred by neurology for evaluation of multiple congenital anomalies that do not fit a well-delineated genetic syndrome, and whole genome sequencing (WGS) is being requested to identify an underlying genetic etiology. Prior karyotype testing was nondiagnostic. There is a family history of a maternal aunt with a congenital anomaly. Pre-test genetic counseling was completed with a genetic specialist and results will be reviewed with the family and the neurology team, with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case7682,12,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_gpt_5_mini_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_mini_update', 'top1_30retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_mini_update']","This 9-year-old child was referred by a developmental pediatrician for evaluation of multiple congenital abnormalities affecting different organ systems and whole exome sequencing (WES) is being requested to identify a potential genetic cause; prior karyotype testing was nondiagnostic, there is a family history of developmental delay in a sibling, and pre-test counseling was completed with a genetic specialist with plans for post-test follow-up, and the family has coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case10529,11,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_mini_update', 'top1_30retrieve_gpt_5_mini_gpt_5_update', 'top1_30retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_mini_update']","The child is a 6-year-old with apparent nonsyndromic developmental delay and intellectual disability who was referred by neurology for genetic evaluation; Fragile X testing was previously performed and was nondiagnostic, and there is a family history of neurologic disease in a maternal uncle with dystonia and ataxia. The family has seen a genetic counselor multiple times and pre-test counseling is complete with plans for post-test follow-up, and whole exome sequencing (WES) is being pursued with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case18257,11,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_mini_update']","The 64-year-old patient has a history of breast cancer diagnosed at age 50 or younger and is being evaluated for BRCA1/2 testing to assess hereditary breast and ovarian cancer risk. Chromosomal microarray (CMA) testing was previously performed and was nondiagnostic, family history is notable for a sibling with short stature, the test was ordered by the patient's general practitioner, there is no documentation of prior genetic counseling, and coverage is through Cigna.",Cigna_MOL.TS_.238.A_BRCA_Analysis_eff01.01.2025_pub09.10.2024_1.pdf,No,Not Specified,Not Specified
Case17929,11,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_gpt_5_mini_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_mini_update', 'top1_30retrieve_gpt_5_mini_gpt_5_update', 'top1_30retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']","Referred by a neurologist, a 7-year-old child covered by UHC is being evaluated for a major abnormality affecting at least one organ system and tumor chromosomal microarray (CMA) testing has been requested to assess for genomic imbalance after prior karyotype testing was nondiagnostic, the family history is notable for a known BRCA1/2 pathogenic variant identified in the mother and a maternal aunt, and the child has had multiple pretest counseling sessions with a genetic counselor with plans for post-test follow-up with neurology and genetics.",United Healthcare_chromosome-microarray-testing.pdf,Yes,Not Specified,Not Specified
Case15557,10,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']","A 15-year-old referred by neurology for evaluation of a congenital anomaly present since birth is being evaluated with whole genome sequencing (WGS) to identify an underlying genetic etiology, and prior fluorescent in situ hybridization (FISH) testing was nondiagnostic; the patient has a sibling with a similar congenital anomaly and has been seen by a genetic counselor multiple times with plans for post-test counseling and coordination of care, and testing is being pursued with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case1501,10,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_gpt_5_mini_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']","The patient is a 2-year-old child referred by a developmental pediatrician for evaluation of multiple congenital anomalies and ongoing developmental concerns, and prior karyotype testing was nondiagnostic; there is a family history of Long QT syndrome in the mother. Whole exome sequencing (WES) is being ordered to identify an underlying genetic etiology, pre-test genetic counseling has been completed with plans for post-test follow-up, and the family has coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case950,10,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_mini_update']","The 38-year-old patient is being evaluated by a medical geneticist for unexplained epileptic encephalopathy with onset before three years of age and has not had prior epilepsy multigene panel testing, so whole exome sequencing (WES) is being pursued to look for an underlying genetic cause; karyotype testing was previously performed and was nondiagnostic. The family history is notable for an uncle with metastatic, high-risk prostate cancer with intraductal/cribriform histology. The patient has seen a genetic counselor multiple times, has coverage through UHC, and plans are in place for post-test counseling and follow-up.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case10917,9,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_mini_update', 'top1_30retrieve_gpt_5_mini_gpt_5_update', 'top1_30retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_mini_gpt_5_mini_update']","The patient is an 8-week-old infant evaluated by a medical geneticist for persistent conjugated hyperbilirubinemia not attributed to total parenteral nutrition-associated cholestasis, and whole exome sequencing (WES) has been ordered to evaluate for an underlying genetic cause; family history is notable for an older sibling with multiple congenital anomalies, and Fragile X testing was previously performed and was nondiagnostic; pre-test counseling was completed with a genetic specialist and the family has coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Not Specified,Yes,Yes
Case5885,8,"['top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_mini_update', 'top1_30retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_mini_update']","An 11-year-old patient was referred by neurology for evaluation of a major abnormality affecting at least one organ system and whole genome sequencing (WGS) is requested to investigate an underlying genetic cause, Fragile X testing was previously performed and was nondiagnostic, and there is a family history of long QT syndrome in the mother; pre-test counseling was discussed with a genetic specialist and plans for post-test follow-up are in place with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Not Specified,Yes,Yes
Case4982,8,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_mini_update', 'top1_30retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']","An 11-year-old with a history of Hirschsprung disease was referred by a developmental pediatrician for genetic evaluation and is being considered for whole exome sequencing (WES) to evaluate for an underlying genetic etiology; prior fluorescence in situ hybridization (FISH) testing was nondiagnostic, and the patient has a sibling who developed epileptic encephalopathy before age three, raising concern for a heritable syndromic or neurodevelopmental condition; the family has coverage through UHC and has met with a genetic counselor multiple times for pre-test counseling with plans for post-test result disclosure and multidisciplinary follow-up.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Not Specified,Yes,Yes
Case19255,8,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']","The patient is a 38-year-old woman with a history of two separate primary breast cancers who was referred by her neurologist for BRCA1/2 testing to evaluate for hereditary breast and ovarian cancer predisposition, she reports a family history notable for a father with metastatic prostate cancer, prior fluorescence in situ hybridization testing was nondiagnostic, and pre-test counseling was completed with a genetic specialist with testing to be pursued with coverage through UHC.",United Healthcare_genetic-testing-hereditary-cancer.pdf,Yes,Not Specified,Not Specified
Case14127,8,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_gpt_5_mini_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_mini_update', 'top1_30retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_mini_update']","Seventeen-year-old referred to medical genetics for evaluation of global developmental delay (GDD) with lifelong cognitive and adaptive deficits, and whole exome sequencing (WES) is being pursued to investigate an underlying genetic etiology; prior fluorescence in situ hybridization (FISH) testing was nondiagnostic. There is a family history of epileptic encephalopathy in a sibling with onset before three years of age. The medical geneticist is coordinating testing, the patient saw a genetic counselor for pre-test counseling and will return for post-test counseling, and the testing will be submitted with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case10363,7,"['top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_mini_update', 'top1_30retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_mini_update']",The patient is a 7-year-old child with a congenital anomaly present since birth who was referred by the general practitioner for whole genome sequencing (WGS) after fluorescence in situ hybridization (FISH) testing was nondiagnostic. The family history is notable for a maternal aunt with pancreatic cancer and the family has coverage through UHC. The patient has been seen multiple times by a genetic counselor for pre-test counseling and plans for post-test follow-up are in place. WGS is being pursued to provide a comprehensive genomic evaluation given the longstanding congenital findings and prior nondiagnostic targeted testing.,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case14371,7,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_mini_update', 'top1_30retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']","An 11-year-old with complex neurodevelopmental disorder and autism spectrum disorder is being evaluated by the general pediatrician who has ordered whole exome sequencing (WES) to investigate an underlying genetic etiology; prior Fragile X testing was nondiagnostic, and there is a family history of a maternal aunt with a persistent severe immunologic disorder, which may inform interpretation of results, and the family met with a genetic counselor before testing with plans for post-test follow-up, with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case3465,7,"['top1_30retrieve_gpt_5_gpt_5_mini_update', 'top1_30retrieve_gpt_5_mini_gpt_5_update', 'top1_30retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_mini_update']","The patient is a 2-year-old being evaluated by a medical geneticist for developmental delay and intellectual disability without a specific syndrome suspected, and whole genome sequencing (WGS) has been ordered to search for an underlying genetic etiology with coverage through UHC, prior Fragile X testing was nondiagnostic, and there is a family history of Long QT syndrome in the patient's father; pre-test counseling was completed with a genetic counselor and plans are in place for post-test counseling and result review.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case11124,6,"['top1_10retrieve_gpt_5_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']","An infant is presenting for evaluation of developmental delay and whole-exome sequencing (WES) has been ordered with coverage through UHC, following referral by an oncologist; pre-test counseling was completed and post-test genetic counseling is planned after results are returned. Prior fluorescence in situ hybridization testing was nondiagnostic. The family history is notable for an older sibling who had significant hearing impairment diagnosed in childhood, which raises concern for a hereditary etiology and supports comprehensive exomic testing.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case11981,6,"['top1_10retrieve_gpt_5_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']","The patient is a 9-year-old child referred by neurology for evaluation of a history of abnormal muscle tone noted in infancy that has persisted with ongoing motor concerns and developmental surveillance; fragile X testing was previously performed and was nondiagnostic. Whole genome sequencing (WGS) is being requested to evaluate for an underlying genetic etiology after pre-test discussion with a genetic specialist, and the family reports coverage through UHC. Family history is notable for a maternal uncle with a persistent severe immunologic disorder, which has been considered in the differential and counseling.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case11855,6,"['top1_10retrieve_gpt_5_gpt_5_mini_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']","The patient is a 14-year-old being evaluated by a developmental pediatrician for a congenital anomaly affecting a single organ system with concern for an underlying genetic etiology, and chromosomal microarray (CMA) is being ordered to assess for copy number variants associated with developmental disorders; Fragile X testing was previously performed and was nondiagnostic. There is a family history notable for a maternal aunt with triple-negative breast cancer, which was discussed as part of the risk assessment during pre-test counseling. Pre-test counseling was completed with a genetic specialist and plans for post-test follow-up were made, and testing will be pursued with coverage through UHC.",United Healthcare_chromosome-microarray-testing.pdf,Yes,Not Specified,Not Specified
Case6451,6,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_gpt_5_mini_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_30retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update']","The 7-week-old infant was evaluated by a developmental pediatrician for significant hypotonia and whole genome sequencing (WGS) is being pursued to identify a potential genetic cause. The family reports that the mother has a history of a persistent, severe immunologic or hematologic disorder. A prior karyotype was nondiagnostic. Pre-test counseling has been completed and post-test follow-up with genetics is planned, and testing is being obtained with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case10850,6,"['top1_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_update']","The patient is a 13-year-old with global developmental delay being evaluated by a developmental pediatrician and whole genome sequencing (WGS) has been ordered to search for an underlying genetic etiology; prior fluorescence in situ hybridization (FISH) testing was nondiagnostic, there is a family history of an aunt with dysmorphic features, and the family completed pre-test genetic counseling with plans for post-test follow-up, with testing pursued through UHC coverage.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case1778,5,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update']","The patient is a 14-year-old adolescent referred by the primary care physician for genetic evaluation of an ocular coloboma, and whole exome sequencing (WES) has been requested for diagnostic clarification; prior fluorescence in situ hybridization testing was nondiagnostic.",Cigna_MOL.TS_.235.C_Whole_Exome_Sequencing_Cigna_eff01.01.2025_pub09.20.2024.pdf,No,Yes,Yes
Case5380,5,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update']","An 8-week-old infant is referred by neurology for evaluation of high-risk brief resolved unexplained events (BRUE) with recurrent witnessed seizure-like episodes, and whole genome sequencing (WGS) is requested to assess for an underlying genetic cause; prior chromosomal microarray (CMA) testing was nondiagnostic, and there is a maternal history of short stature as a growth abnormality, the family declined pre-test genetic counseling, and testing will be pursued with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case13517,5,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_30retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_mini_update']","The 16-year-old patient was referred by a developmental pediatrician for evaluation of conjugated hyperbilirubinemia not attributable to total parenteral nutrition–associated cholestasis, and whole exome sequencing (WES) was ordered to evaluate for an underlying genetic cause given a sibling with laboratory abnormalities suggestive of an inborn error of metabolism. Fragile X testing was previously performed and was nondiagnostic. Pre-test counseling was completed with a genetic counselor and post-test counseling is planned, and testing will be billed through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Not Specified,Yes,Yes
Case16246,4,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_mini_update']","The patient is a 35-year-old woman with a personal history of breast cancer who meets criteria for hereditary testing because her diagnosis occurred before age 50, and she is being referred by her gynecologist for BRCA1 and BRCA2 testing with coverage through UHC; she reports a family history notable for an uncle with pancreatic cancer, prior karyotype testing was performed and was nondiagnostic, and no pre-test genetic counseling has been conducted.",United Healthcare_genetic-testing-hereditary-cancer.pdf,Yes,Not Specified,Not Specified
Case8621,4,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update']","A 2-year-old child with a complex neurodevelopmental disorder with autism is undergoing evaluation with whole exome sequencing (WES) to seek a unifying diagnosis after prior chromosomal microarray (CMA) testing was nondiagnostic; the test was ordered by the child’s oncologist and is planned with coverage through UHC, the family reports an uncle with a congenital anomaly as relevant family history, and the family has met with a genetic counselor multiple times with pre-test counseling completed and plans for post-test follow-up.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Not Specified,Yes,Yes
Case16487,4,"['top1_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']","The newborn is being evaluated for a high-risk brief resolved unexplained event (BRUE) characterized by recurrent events in the absence of respiratory infection, and whole exome sequencing (WES) has been ordered by the oncologist following nondiagnostic fluorescence in situ hybridization (FISH) testing, the family history is notable for a maternal aunt with a persistent severe immunologic or hematologic disorder, the infant has coverage through UHC, and pre-test counseling was completed with plans for post-test genetic follow-up.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case13613,4,"['top1_10retrieve_gpt_5_gpt_5_mini_update', 'top1_10retrieve_gpt_5_mini_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update']","At 22 weeks' gestation fetal imaging identified multiple structural anomalies and the pregnancy was referred by neurology for evaluation with whole exome sequencing (WES) to assess potential genetic etiologies that could inform postnatal management and counseling. Fragile X testing was previously performed and was nondiagnostic. There is a family history of dysmorphic features in a maternal aunt, and pre-test discussion occurred with a genetic specialist and testing will be pursued with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case19321,4,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update']","The patient is a 1-year-old referred by a neurologist for evaluation of a complex neurodevelopmental disorder with features concerning for autism spectrum disorder, and whole exome sequencing (WES) is being pursued to investigate a possible genetic etiology; prior chromosomal microarray (CMA) testing was nondiagnostic. A maternal aunt is reported to have multiple congenital anomalies, pre-test genetic counseling was completed, and plans are in place for post-test follow-up, with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Not Specified,Yes,Yes
Case7604,4,"['top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']",The neonate was referred by a neurologist for evaluation of multiple congenital anomalies affecting several organ systems and whole genome sequencing (WGS) has been ordered to evaluate for an underlying genetic etiology. Fluorescence in situ hybridization (FISH) testing was performed previously and was nondiagnostic. There is a family history notable for an older sibling with multiple congenital anomalies. The family has coverage through UHC and they declined genetic counseling at this time.,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case9978,4,"['top1_30retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_mini_gpt_5_mini_update']","The 53-year-old patient is undergoing whole exome sequencing (WES) at the request of the neurologist to evaluate an epileptic encephalopathy that began before age three and has persisted into adulthood; Fragile X testing was previously performed and was nondiagnostic. The patient has a brother with an inborn error of metabolism, has coverage through UHC, and completed pre-test counseling with a genetic counselor with plans for post-test follow-up.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case6478,3,"['top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_30retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update']","A 52-year-old man with metastatic prostate cancer is being referred by his general practitioner for germline BRCA1 and BRCA2 testing because of a family history notable for a father with pancreatic cancer; he has had no prior genetic testing, pre-test genetic counseling was not completed, and testing is being pursued with coverage through UHC to inform therapeutic options and cascade testing for at-risk relatives with plans for post-test counseling and oncology follow-up once results are available.",United Healthcare_genetic-testing-hereditary-cancer.pdf,No,Not Specified,Not Specified
Case12834,3,"['top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_mini_gpt_5_update']","The patient is a 16-year-old referred by a developmental pediatrician for evaluation of a complex neurodevelopmental disorder affecting at least one organ system, and chromosomal microarray (CMA) testing has been ordered although the requisition specifies a tumor-type rather than a germline assay; prior Fragile X testing was nondiagnostic. There is a family history notable for a maternal uncle with a movement disorder described as dystonia and ataxia, genetic counseling is not documented in the record, and testing will be billed through Cigna.",Cigna_MOL.TS_.344.A_Chromosomal_Microarray_Solid_Tumors_eff01.01.2025_pub09.11.2024_0.pdf,Yes,Not Specified,Not Specified
Case17822,3,"['top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_mini_update']","The patient is a 13-year-old referred to medical genetics for evaluation of multiple congenital anomalies affecting different organ systems, and whole genome sequencing (WGS) has been ordered as the next-tier diagnostic test after a nondiagnostic chromosomal microarray (CMA). The family history is notable for a sibling with short stature, genetic counseling was declined prior to testing, and the order was placed by a medical geneticist with coverage through UHC, with plans to review results and coordinate further evaluation and management as indicated.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case5303,3,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_update', 'top1_30retrieve_gpt_5_mini_gpt_5_update']","The 37-year-old patient was referred by neurology for BRCA1 and BRCA2 testing in the setting of a major abnormality affecting at least one organ system and a family history notable for a brother who died suddenly and unexpectedly before age 35; no prior genetic testing has been performed and no pre-test genetic counseling was conducted, and the patient has coverage through UHC.",United Healthcare_genetic-testing-hereditary-cancer.pdf,No,Not Specified,Not Specified
Case10451,3,"['top1_30retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_update']","The patient is a 10-year-old with moderate to severe intellectual disability diagnosed in childhood who was referred by neurology for whole exome sequencing (WES) to evaluate an unexplained neurodevelopmental disorder; prior chromosomal microarray (CMA) testing was nondiagnostic. There is a family history of a sibling who had a brief resolved unexplained event characterized by altered level of responsiveness with cyanosis, pallor, and irregular breathing. The neurologist placed the order, there is no documentation of prior genetic counseling, and testing will be pursued with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Not Specified,Yes,Yes
Case3677,3,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update']","She is a 46-year-old woman with a personal history of breast cancer who is undergoing BRCA1/2 testing because of a close relative with pancreatic cancer and multiple other primary solid tumors on the same side of the family; prior chromosomal microarray (CMA) testing was nondiagnostic. The patient was referred by a nurse practitioner and completed pre-test genetic counseling with plans for post-test follow-up, and testing will be billed to UHC. Her family history is notable for a mother with pancreatic cancer and at least two additional affected relatives on the maternal side.",United Healthcare_genetic-testing-hereditary-cancer.pdf,Yes,Not Specified,Not Specified
Case13406,3,"['top1_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_mini_gpt_5_update']","The infant is 6 weeks of age and is being evaluated for concern of global developmental delay, with a family history notable for a sibling who experienced a brief resolved unexplained event described as altered level of responsiveness with cyanosis, pallor, and irregular breathing; chromosomal microarray (CMA) was previously performed and was nondiagnostic. Whole genome sequencing (WGS) has been ordered by a medical geneticist to assess for an underlying genetic etiology, pre-test counseling has been completed, and the family will follow up with the genetic counselor after results, with testing submitted for coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case11514,2,"['top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']","The 10-year-old patient is being evaluated for conjugated hyperbilirubinemia not attributable to total parenteral nutrition and whole exome sequencing (WES) has been requested to investigate a potential genetic cause of cholestatic liver disease; a chromosomal microarray (CMA) was previously performed and was nondiagnostic. There is a family history of an inborn error of metabolism in a cousin, which raises concern for an inherited metabolic disorder contributing to the hepatic phenotype. The test was ordered by the patient's oncologist, coverage is through UHC, and there is no documentation of pre-test genetic counseling.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Not Specified,Yes,Yes
Case18868,2,"['top1_30retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update']","The patient is a 41-year-old with a diagnosis of primary peritoneal carcinoma who was evaluated by a medical geneticist and for whom whole genome sequencing (WGS) has been ordered to assess for an underlying hereditary cancer predisposition; prior karyotype testing was nondiagnostic. Her mother reportedly has a persistent and severe hematologic disorder, which raised concern for a heritable syndrome affecting cancer and hematologic risk. Coverage is through Cigna, and there was no documented record of pre-test genetic counseling in the materials provided.",Cigna_MOL.TS_.306.C_Whole_Genome_Sequencing_Cigna_eff01.01.2025_pub09.10.2024.pdf,No,Yes,Yes
Case4067,2,"['top1_30retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_gpt_5_update']","The 5-year-old was referred by a developmental pediatrician for evaluation of significant hypotonia and whole exome sequencing (WES) has been ordered to assess for an underlying genetic etiology; prior chromosomal karyotype testing was nondiagnostic, and there is a family history of sudden unexplained death in a paternal uncle before age 35 that raises concern for a heritable disorder, with the family reporting coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case14408,2,"['top1_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_update']","The patient is a 75-year-old who was referred by a family medicine physician for BRCA1/2 testing because of dysmorphic features and a family history notable for a brother with breast cancer; there is no prior genetic testing, pre-test counseling was completed and post-test follow-up with a genetic counselor is planned, and testing will be billed through Cigna.",Cigna_MOL.TS_.238.A_BRCA_Analysis_eff01.01.2025_pub09.10.2024_1.pdf,Yes,Not Specified,Not Specified
Case1130,2,"['top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_mini_gpt_5_mini_update']","The 68-year-old patient was referred by cardiology for evaluation of persistent seizures and is undergoing whole exome sequencing (WES) to assess for an underlying genetic etiology; prior fluorescence in situ hybridization (FISH) testing was nondiagnostic, and the patient reports a sister with ovarian, fallopian tube, or peritoneal carcinoma in the family, which was reviewed during counseling. The patient has seen a genetic counselor multiple times with plans for post-test follow-up and testing is being arranged with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case16126,2,"['top1_30retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']","The patient is a 6-week-old infant being evaluated for multiple congenital anomalies and BRCA1 and BRCA2 testing has been ordered by a gynecologist. FISH testing was previously performed and was nondiagnostic, the parents are reported to be consanguineous, pre-test counseling has been completed with plans for post-test follow-up with a genetic counselor, and testing will be billed through BCBS_FEP.",BCBS_FEP_20402 Germline Genetic Testing for.pdf,No,Not Specified,Not Specified
Case1428,2,"['top1_10retrieve_gpt_5_gpt_5_mini_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update']","The three-week-old infant is being evaluated by a medical geneticist for Hirschsprung disease and whole genome sequencing (WGS) has been ordered to assess for an underlying genetic cause given a family history of an older sibling with severe intellectual disability diagnosed by age 18. Fragile X testing was previously performed and was nondiagnostic, and there is no documented pre-test genetic counseling. Testing will be submitted through UHC for coverage.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case7376,2,"['top1_10retrieve_gpt_5_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_mini_update']","The patient is a 73-year-old referred by a neurologist for evaluation of a major abnormality involving at least one organ system that remains unexplained, and whole exome sequencing (WES) has been ordered for diagnostic clarification. Prior fluorescent in situ hybridization testing was nondiagnostic. The patient reports that a sister had triple negative breast cancer, which raises concern for an underlying heritable predisposition. Pre-test counseling was completed with a genetic specialist and testing will proceed with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Not Specified,Yes,Yes
Case8485,2,"['top1_10retrieve_gpt_5_gpt_5_update', 'top1_10retrieve_gpt_5_mini_gpt_5_update']","An 8-year-old child with hypotonia first noted in infancy is being evaluated by the general pediatrician for persistent motor delay and evolving tone abnormalities, and whole exome sequencing (WES) has been ordered to investigate a possible genetic etiology; prior Fragile X testing was nondiagnostic, the family reports a sibling with autism spectrum disorder, pre-test genetic counseling was not performed, and testing will be submitted with coverage through Cigna.",Cigna_MOL.TS_.235.C_Whole_Exome_Sequencing_Cigna_eff01.01.2025_pub09.20.2024.pdf,No,Yes,Yes
Case8661,2,"['top3_30retrieve_gpt_5_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']",The patient is a 7-year-old referred by the child's neurologist for evaluation of a significant hearing or visual impairment identified in childhood and whole genome sequencing (WGS) is requested to investigate a possible genetic cause. Fragile X testing was previously performed and was nondiagnostic. There is a family history of a sibling who developed an epileptic encephalopathy before three years of age. Genetic counseling was offered but the family declined pre-test counseling; testing is being pursued with coverage through UHC and plans are in place to provide post-test genetic counseling and genetics follow-up if results are informative.,United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case5605,2,"['top1_30retrieve_gpt_5_mini_gpt_5_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']","The patient is an 11-year-old being evaluated for a major congenital cardiac anomaly and was referred by an obstetrician for whole genome sequencing (WGS) to assess for an underlying genetic cause. A prior chromosomal microarray (CMA) was nondiagnostic, pre-test counseling was completed with a genetic specialist, and insurance coverage is through BCBS_FEP. Family history is notable for a maternal aunt with pancreatic cancer.",BCBS_FEP_204102 Whole Exome and.pdf,No,Yes,Yes
Case3359,2,"['top1_10retrieve_gpt_5_mini_gpt_5_update', 'top3_10retrieve_gpt_5_gpt_5_update']","The patient is a 4-year-old child referred by a developmental pediatrician for evaluation of significant hypotonia and ongoing developmental concerns; chromosomal microarray (CMA) testing was previously performed and was nondiagnostic, and there is a family history notable for a sibling with developmental delay. Whole exome sequencing (WES) is being requested to evaluate for an underlying genetic etiology, pre-test counseling has been completed with a genetic counselor on multiple occasions, and plans for post-test follow-up and care coordination are in place with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,Not Specified,Yes,Yes
Case2211,2,"['top1_10retrieve_gpt_5_mini_gpt_5_update', 'top1_30retrieve_gpt_5_gpt_5_update']","A 21-year-old patient is referred by a general practitioner for BRCA1 and BRCA2 (breast cancer susceptibility) testing because of a personal history of a primary solid tumor and reports of at least two additional affected blood relatives on the same side of the family; the patient states that the mother carries a known BRCA2 pathogenic variant. No prior genetic testing has been performed, and pre-test counseling was completed with a genetic specialist with plans for post-test follow-up. Testing is being requested through UHC to clarify hereditary cancer risk and to guide management for this young adult.",United Healthcare_genetic-testing-hereditary-cancer.pdf,Yes,Not Specified,Not Specified
Case3592,2,"['top1_10retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_gpt_5_mini_update']","The patient is a neonate evaluated by a developmental pediatrician for unexplained epileptic encephalopathy with neonatal onset and no prior epilepsy multigene panel testing; chromosomal microarray (CMA) testing for developmental disorders is being requested. A prior chromosomal microarray was nondiagnostic. There is a family history of an older sibling with unexplained developmental regression unrelated to autism or epilepsy. Pre-test counseling was discussed with a genetic specialist and post-test follow-up is planned, and testing is being submitted with coverage through Cigna.",Cigna_MOL.TS_.150A_CMA_for_Developmental_Disorders_and_Prenatal_Diagnosis_eff01.01.2025_pub09.10.2024_1.pdf,Not Specified,No,No
Case18281,2,"['top3_10retrieve_gpt_5_gpt_5_mini_update', 'top3_30retrieve_gpt_5_mini_gpt_5_update']","The patient is a 6-year-old child referred by the cardiologist for evaluation of multiple congenital anomalies that do not fit a well-delineated genetic syndrome, and the cardiologist has ordered whole genome sequencing (WGS) to assess for an underlying genetic etiology. Fragile X testing was previously performed and was nondiagnostic. There is a family history of an inborn error of metabolism in a sibling. No genetic counseling was conducted prior to testing and the family has coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case13675,1,['top3_10retrieve_gpt_5_mini_gpt_5_update'],"The patient is an 8-week-old infant referred by a neonatologist for evaluation of significant congenital hearing and/or visual impairment identified in early infancy, and whole genome sequencing (WGS) is being pursued for diagnostic clarification; prior fluorescence in situ hybridization testing was nondiagnostic. The family history is notable for a father with long QT syndrome, which will be considered in interpretation of any cardiac-associated findings. There is no documentation of pre-test genetic counseling and testing is being requested with coverage through UHC with planned post-test follow-up by the neonatal team.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case15820,1,['top3_10retrieve_gpt_5_mini_gpt_5_mini_update'],"The patient is a 31-year-old adult followed by neurology for developmental delay and intellectual disability without a suspected specific syndrome, and chromosomal microarray (CMA) has been ordered to evaluate for underlying copy number variants; no prior genetic testing has been reported, and the patient has completed multiple pre-test counseling sessions with a genetic counselor with plans for post-test follow-up, with insurance coverage through Cigna, and a pertinent family history of a mother who was diagnosed with breast cancer before age 50.",Cigna_MOL.TS_.150A_CMA_for_Developmental_Disorders_and_Prenatal_Diagnosis_eff01.01.2025_pub09.10.2024_1.pdf,Yes,No,No
Case10427,1,['top1_30retrieve_gpt_5_mini_gpt_5_update'],"An 8-week-old infant was referred by a neurologist for evaluation of significant hypotonia, and whole genome sequencing (WGS) is being requested to identify a potential genetic etiology; fluorescence in situ hybridization (FISH) testing was previously performed and was nondiagnostic. The family history is notable for an older sibling who experienced unexplained developmental regression not related to autism or epilepsy. Pre-test counseling has been completed with a genetic counselor on multiple occasions and post-test follow-up is planned, and testing is being ordered with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case12792,1,['top1_30retrieve_gpt_5_mini_gpt_5_update'],"A 12-year-old was referred by a family medicine physician for BRCA1/2 testing in the setting of congenital choanal atresia and a reported growth abnormality in the mother. Prior fluorescent in situ hybridization (FISH) testing was nondiagnostic. Pre-test genetic counseling has been completed and post-test follow-up is planned, and testing will be billed through BCBS_FEP.",BCBS_FEP_20402 Germline Genetic Testing for.pdf,No,Not Specified,Not Specified
Case3422,1,['top1_30retrieve_gpt_5_gpt_5_update'],"The patient is a 34-year-old referred by oncology for evaluation of congenital choanal atresia and consideration of whole-exome sequencing (WES) to assess for an underlying genetic etiology after a nondiagnostic chromosomal microarray (CMA); the patient has Cigna coverage, has seen a genetic counselor multiple times, and reports a mother who was diagnosed with breast cancer at age 50.",Cigna_MOL.TS_.235.C_Whole_Exome_Sequencing_Cigna_eff01.01.2025_pub09.20.2024.pdf,Not Specified,Yes,Yes
Case19905,1,['top1_10retrieve_gpt_5_gpt_5_update'],"The patient is a 3-year-old referred by the developmental pediatrician for evaluation of multiple congenital anomalies and is being considered for whole exome sequencing (WES) with coverage through UHC; prior karyotype testing was nondiagnostic, there is a family history notable for a mother with long QT syndrome, and no genetic counseling has been conducted to date.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case18882,1,['top3_10retrieve_gpt_5_mini_gpt_5_update'],"An 8-year-old child is referred by a developmental pediatrician for evaluation of multiple congenital anomalies affecting several organ systems, and whole exome sequencing (WES) is being requested with coverage through UHC; prior fluorescent in situ hybridization (FISH) testing was nondiagnostic, the family reports that the mother has long QT syndrome, and the family declined pre-test genetic counseling but agreed to proceed with testing with plans to coordinate post-test counseling to review results and management.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
Case8710,1,['top1_10retrieve_gpt_5_gpt_5_update'],"The patient is a 12-year-old who was referred by a developmental pediatrician for genetic evaluation of autism spectrum disorder with at least one additional abnormality affecting another organ system, and whole exome sequencing (WES) has been requested to investigate an underlying genetic etiology. Prior karyotype testing was nondiagnostic. There is a reported family history of neurologic disease in a paternal uncle characterized by dystonia and ataxia. No pre-test genetic counseling was documented and the family plans to proceed with testing with coverage through UHC.",United Healthcare_whole-exome-and-whole-genome-sequencing.pdf,No,Yes,Yes
